Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - HIV-1 Associated CNS Complications (Overview) : Article by

HIV Resource Center
HIV Resource Center

View all HIV Articles

HIV Multimedia Library


Quick Find
Authors & Editors
Introduction
Differentials
Workup
Treatment
Follow-up
Miscellaneous
References

Related Articles
Alzheimer Disease

Aphasia

Cardioembolic Stroke

Cavernous Sinus Syndromes

Cerebral Venous Thrombosis

EEG in Dementia and Encephalopathy

Epidural Hematoma

Frontal and Temporal Lobe Dementia

Frontal Lobe Syndromes

Herpes Simplex Encephalitis

HIV-1 Associated Cerebrovascular Complications

HIV-1 Associated CNS Conditions: Meningitis

HIV-1 Associated Opportunistic Infections: CNS Cryptococcosis

HIV-1 Associated Opportunistic Infections: CNS Toxoplasmosis

HIV-1 Associated Opportunistic Infections: Cytomegalovirus Encephalitis

HIV-1 Associated Opportunistic Infections: PML

HIV-1 Associated Opportunistic Neoplasms: CNS Lymphoma

HIV-1 Associated Vacuolar Myelopathy

HIV-1 Encephalopathy and AIDS Dementia Complex

Huntington Disease

Intracranial Epidural Abscess

Intracranial Hemorrhage

Lacunar Syndromes

Neurocysticercosis

Posterior Cerebral Artery Stroke

Primary CNS Lymphoma

Spinal Cord Hemorrhage

Spinal Cord Infarction

Spinal Epidural Abscess

Subdural Empyema

Subdural Hematoma

Tuberculous Meningitis

Uremic Encephalopathy

Vasculitic Neuropathy

Viral Encephalitis

Viral Meningitis




Patient Education
Immune System Center

Dementia Center

Sexually Transmitted Diseases Center

HIV/AIDS Overview

HIV/AIDS Causes

HIV/AIDS Symptoms

HIV/AIDS Treatment

Dementia Due to HIV Infection Overview




Author: Niranjan N Singh, MD, DNB, Fellow in Neurophysiology, Department of Neurology, St Louis University School of Medicine

Niranjan N Singh is a member of the following medical societies: American Academy of Neurology

Coauthor(s): Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St. Louis VAMC, Associate Program Director, Associate Professor, Departments of Neurology, Molecular Virology, and Molecular Microbiology and Immunology, Saint Louis University School of Medicine; R Charles Callison Jr, MD, Staff Physician, Department of Neurology, St Louis University School of Medicine

Editors: William J Nowack, MD, Associate Professor, Department of Neurology, Epilepsy Center, University of Kansas Medical Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale; Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital; Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants

Author and Editor Disclosure

Synonyms and related keywords: acquired immunodeficiency syndrome, AIDS, human immunodeficiency virus, HIV infection, HIV-1–associated cognitive/motor complex, AIDS dementia complex, ADC, vacuolar myelopathy, peripheral neuropathies, CNS lymphoma, Kaposi sarcoma, Kaposi's sarcoma, progressive multifocal leukoencephalopathy, PML, cryptococcal meningitis, tuberculous meningitis, cerebrovascular diseases, toxoplasmosis, neurocysticercosis, cytomegalovirus infection, CMV, neurologic complications of HIV, immune reconstitution inflammatory syndrome, IRIS

Background

Multiform CNS complications accompany HIV infection. The HIV-1–associated cognitive/motor complex or AIDS dementia complex (ADC), vacuolar myelopathy, and certain peripheral neuropathies are several conditions that may be caused, directly or indirectly, by HIV itself. Conditions caused by infectious, autoimmune, or neoplastic processes secondary to immunodeficiency include CNS lymphoma, Kaposi sarcoma, progressive multifocal leukoencephalopathy (PML), cryptococcal meningitis, tuberculous meningitis, cerebrovascular diseases, some neuropathies and myopathies, toxoplasmosis, neurocysticercosis, and cytomegalovirus (CMV) infection. Some neurologic conditions are caused by antiretroviral drugs. In addition, AIDS patients are susceptible to the same neurologic diseases as patients who do not have HIV infection.

In AIDS, a clinical presentation often cannot be explained with a single diagnosis. New-onset neurologic complications often are superimposed on an ongoing process with a different etiology. Clinical features reflect the sum of deficits at several anatomic sites.

The manifestations of AIDS and its neurologic complications differ in children, whose immune and nervous systems are infected at an immature stage, whether in utero, during delivery, or postpartum. CNS complications tend to progress more rapidly in children, probably because of the inability of their immune systems to mount an appropriate T-cell, B-cell, or cytokine response to the infection.

Neurologic involvement in HIV infection is more frequent in children than in adults. It may take the form of a loss of previously acquired intellectual and motor milestones or of developmental delay. Opportunistic infections due to reactivation of dormant organisms are unusual, as children may not have been exposed yet to the responsible organisms. Distinguishing features include blood vessel calcification in the basal ganglia, large necrotizing cortical and subcortical lesions, microcephaly, and infection of astrocytes.

Pathophysiology

When immune defenses are impaired, opportunistic infections and neoplasms arise, often from reactivation of previously acquired organisms. This mechanism applies to agents such as Toxoplasma gondii and Epstein-Barr virus (EBV). Other organisms, such as the JC or SV40 viruses that cause PML, may be activated directly by HIV gene products.

The likelihood of a particular neurologic syndrome correlates with the clinical stage of HIV infection as reflected by viral load, immune response, and CD4+ lymphocyte counts. This, in turn, is related to the severity of immunodeficiency and autoimmunity and to serum and tissue cytokine levels.

Manifestations at seroconversion are often subclinical but may include meningitis, acute encephalopathy with seizures, confusion, and delirium. HIV enters the CNS soon after initial infection. Early peripheral nerve manifestations include isolated acute cranial nerve palsies and Guillain-Barré syndrome.

Neurologic complications seen in AIDS include ADC, vacuolar myelopathy, opportunistic infections and neoplasms, and chronic neuropathies (usually several years after HIV infection).

Immune reconstitution inflammatory syndrome is a newly recognized  condition that manifests several weeks after starting HAART. There is a paradoxical clinical deterioration despite improving CD4 cell counts and viral load. Antiretroviral naive patients are at particular risk independent of baseline CD4 counts. It can involve any organ system including the nervous system.

Frequency

United States

Neurologic complications are present in more than 40% of patients with HIV. They are the presenting feature of AIDS in 10-20%. At autopsy, the prevalence of neuropathologic abnormalities is 80%.

Mortality/Morbidity

Mortality and morbidity rates reflect risks due to both the neurologic condition and severe immunodeficiency.

Age

Neurologic complications occur at any age.



Alzheimer Disease
Aphasia
Cardioembolic Stroke
Cavernous Sinus Syndromes
Cerebral Venous Thrombosis
EEG in Dementia and Encephalopathy
Epidural Hematoma
Frontal and Temporal Lobe Dementia
Frontal Lobe Syndromes
Herpes Simplex Encephalitis
HIV-1 Associated Cerebrovascular Complications
HIV-1 Associated CNS Conditions: Meningitis
HIV-1 Associated Opportunistic Infections: CNS Cryptococcosis
HIV-1 Associated Opportunistic Infections: CNS Toxoplasmosis
HIV-1 Associated Opportunistic Infections: Cytomegalovirus Encephalitis
HIV-1 Associated Opportunistic Infections: PML
HIV-1 Associated Opportunistic Neoplasms: CNS Lymphoma
HIV-1 Associated Vacuolar Myelopathy
HIV-1 Encephalopathy and AIDS Dementia Complex
Huntington Disease
Intracranial Epidural Abscess
Intracranial Hemorrhage
Lacunar Syndromes
Neurocysticercosis
Posterior Cerebral Artery Stroke
Primary CNS Lymphoma
Spinal Cord Hemorrhage
Spinal Cord Infarction
Spinal Epidural Abscess
Subdural Empyema
Subdural Hematoma
Tuberculous Meningitis
Uremic Encephalopathy
Vasculitic Neuropathy
Viral Encephalitis
Viral Meningitis

Other Problems to be Considered

Immune reconstitution inflammatory syndrome (IRIS)
Brainstem syndromes
Efavirenz-related side effects - Efavirenz has been implicated in relation to various short- and long-term neuropsychiatric side effects including mood lability, concentration difficulties, nightmares, and anxiety.



Lab Studies

  • Multiple ancillary tests need to be performed, even when the level of suspicion is relatively low.

Imaging Studies

  • Imaging studies often make diagnoses rather than just confirming them.
  • The most sensitive study is often MRI with and without gadolinium (or other contrast agents).
  • If MRI is not available or if patient motion is expected to compromise the image, head CT scan without and with intravenous contrast is the next best solution.



Medical Care

Several algorithms have been developed for the evaluation and treatment of adult HIV-seropositive patients with neurologic symptoms and signs. These algorithms proceed through several branch points depending on the results of previous tests.

  • A brain CT scan or MRI with and without contrast is indicated for all patients presenting with altered mental status, headaches, seizures, or focal neurologic signs. MRI is clearly the superior technique but is not available universally.
  • If this initial imaging study is normal, or shows atrophy or focal signal abnormalities but no mass lesion, diagnostic consideration should be given to meningitides, ADC, or PML.
  • If imaging shows 1 or more focal mass lesions with impending herniation, an open biopsy with decompression is indicated. The rarity of toxoplasmosis in children may warrant a brain biopsy without any preceding studies. Treatment for lymphoma, toxoplasmosis, or other opportunistic infections and neoplasms is initiated depending on results.
  • If imaging shows 1 or more focal mass lesions without impending herniation, additional studies are warranted.
  • When available, 201T SPECT or 18FDG-PET scan in conjunction with polymerase chain reaction (PCR) studies of the cerebrospinal fluid (CSF) for EBV can provide strong evidence that a mass lesion represents a lymphoma. This may reduce the need for a stereotactic biopsy.
  • When these studies cannot be conducted, toxoplasmosis serology in conjunction with imaging results will determine how to proceed.
  • In cases of a single mass lesion and negative serology, a stereotactic brain biopsy is indicated.
  • In cases of multiple lesions with negative or positive serology, therapy for toxoplasmosis should be initiated.
  • In cases of multiple or single lesions with positive serology, therapy for toxoplasmosis should be initiated.
  • Immune reconstitution inflammatory syndrome (IRIS) must be considered in patients who deteriorate clinically or radiologically after starting HAART despite improving viral load and CD4 count. Treatment remains empirical; some patients respond to steroids.



Patient Education



Medical/Legal Pitfalls

  • A consultant often faces the challenge of differentiating slow progression of HIV-associated dementia, myelopathy, or neuropathy from an acute, new-onset process such as infection with CMV or toxoplasmosis. Such intervening conditions must be diagnosed rapidly and appropriate treatment initiated expeditiously. Failure to recognize a potentially reversible condition that is fatal if not treated would constitute deviation from the standard of care.



  • American Academy of Neurology. Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Jan 1998;50(1):21-6. [Medline].
  • Antinori A, Ammassari A, Luzzati R. Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Gruppo Italiano Cooperativo AIDS & Tumori. Neurology. Feb 22 2000;54(4):993-7. [Medline].
  • de Gans J, Portegies P. Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin Neurol Neurosurg. 1989;91(3):199-219. [Medline].
  • Fumaz CR, Munoz-Moreno JA, Molto J, et al. Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence. J Acquir Immune Defic Syndr. Apr 15 2005;38(5):560-5. [Medline].
  • Gendelman HE, Lipton SA, Epstein L. The Neurology of AIDS. NY:. Chapman & Hall;1998.
  • Kumwenda JJ, Mateyu G, Kampondeni S, et al. Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke. May 2005;36(5):960-4. [Medline].
  • Price RW, Perry SW. HIV, AIDS, and the Brain. NY: Raven Press:1994.
  • Said G, Saimont AG, Lacroix C. Neurological complications of HIV and AIDS. Philadelphia: WB Saunders Cp; 1998.
  • Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology. Aug 8 2006;67(3):383-8. [Medline].

HIV-1 Associated CNS Complications (Overview) excerpt

Article Last Updated: Aug 27, 2007